#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4044	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2590	465.7	0	.	n	.	0	C756T	SNP	756	756	C	1279	1279	T	594	T	521	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4044	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2590	465.7	0	.	n	.	0	G1207A	SNP	1207	1207	G	1730	1730	A	612	A,G	527,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4044	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2590	465.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1973	1973	T	628	T,A	572,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4044	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2590	465.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1707	1707	C	619	C	533	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6920	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3897	532.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1860	1860	A	633	A	554	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6920	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3897	532.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2494	2494	C	642	C,A	547,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6920	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3897	532.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2568	2568	A	668	A	577	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6920	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3897	532.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3120	3120	C	680	C	577	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	564	folP	852	852	99.88	folP.l15.c4.ctg.1	1801	93.9	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1052	1054	GTA	135;135;136	G;T;A	117;116;117	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	564	folP	852	852	99.88	folP.l15.c4.ctg.1	1801	93.9	1	SNP	p	R228S	0	.	.	682	684	CGC	1124	1126	CGC	135;135;136	C;G;C	108;108;110	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1242	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3707	100.3	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1192	1194	ATA	100;100;99	A;T;A	85;88;83	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1242	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3707	100.3	1	SNP	p	S91F	0	.	.	271	273	TCC	715	717	TCC	106;104;103	T;C,A;C	93;92,1;93	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1242	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3707	100.3	1	SNP	p	D95G	0	.	.	283	285	GAC	727	729	GAC	104;103;103	G;A;C	92;91;92	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1242	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3707	100.3	1	SNP	p	D95N	0	.	.	283	285	GAC	727	729	GAC	104;103;103	G;A;C	92;91;92	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	314	mtrR	633	550	99.27	mtrR.l15.c17.ctg.1	1219	76.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	304	306	ACC	71;71;71	A;C;C	59;59;59	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	184	mtrR_promoter	250	235	100.0	mtrR_promoter.l15.c4.ctg.1	1049	52.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1610	1612	ATC	135;135;135	A;T;C	118;118;117	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1763	1765	GCA	131;130;130	G;C;A	115;115;114	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	1	SNP	p	D86N	0	.	.	256	258	GAC	716	718	GAC	162;161;162	G;A;C	139;141;140	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	1	SNP	p	S87W	0	.	.	259	261	AGT	719	721	AGT	162;162;162	A;G;T	137;142;140	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	1	SNP	p	S87I	0	.	.	259	261	AGT	719	721	AGT	162;162;162	A;G;T	137;142;140	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	1	SNP	p	S87R	0	.	.	259	261	AGT	719	721	AGT	162;162;162	A;G;T	137;142;140	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1238	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3221	115.3	1	SNP	p	S88P	0	.	.	262	264	TCC	722	724	TCC	160;160;160	T;C;C	139;140;140	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1010	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2961	102.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1735	1737	GGC	128;128;128	G;G;C	116;117;118	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1380	1382	GCA	178;178;176	G;C,A;A	156;157,1;156	penA.22.003:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1383	1385	ATC	175;174;174	A;T;C	156;157;156	penA.22.003:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1395	1397	GTG	170;169;169	G;T;G	152;150;151	penA.22.003:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1395	1397	GTG	170;169;169	G;T;G	152;150;151	penA.22.003:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1899	1901	ACC	135;135;136	A;C;C	116;115;119	penA.22.003:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1953	1955	GCG	125;124;124	G;C;G	110;102;107	penA.22.003:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1953	1955	GCG	125;124;124	G;C;G	110;102;107	penA.22.003:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2076	2078	GGT	125;125;126	G;G;T	109;109;109	penA.22.003:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2085	2087	GGC	122;122;122	G;G;C	106;107;106	penA.22.003:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.003	penA.22.003	1	1	27	1122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2714	124.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2103	2105	CCG	125;126;126	C;C;G	99;107;100	penA.22.003:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	1430	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3383	126.8	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1667	1669	ACG	134;133;134	A;C;G,A	113;109;113,1	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	1430	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3383	126.8	0	.	p	.	0	M714I	NONSYN	2140	2142	ATG	2684	2686	ATA	140;140;141	A;T;A	117;117;120	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	1430	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3383	126.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1805	1807	CTG	140;141;141	C;T;G	120;121;120	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	658	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2162	91.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	535	537	GGC	104;103;104	G;G,C;C	91;91,1;93	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	658	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2162	91.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	717	717	C	120	C	100	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	346	porB1a	984	984	93.81	porB1a.l15.c17.ctg.1	1544	66.4	0	.	p	.	0	T9A	NONSYN	25	27	ACT	389	391	GCT	115;116;116	G;C;T	91;93;94	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	346	porB1a	984	984	93.81	porB1a.l15.c17.ctg.1	1544	66.4	0	.	p	.	0	A29V	NONSYN	85	87	GCC	449	451	GTC	121;121;122	G;T;C	98;100;99	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	346	porB1a	984	984	93.81	porB1a.l15.c17.ctg.1	1544	66.4	0	.	p	.	0	A38D	NONSYN	112	114	GCT	476	478	GAT	115;115;114	G;A;T	98;98;97	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	346	porB1a	984	984	93.81	porB1a.l15.c17.ctg.1	1544	66.4	0	.	p	.	0	.	MULTIPLE	115	117	TAC	479	482	CACA	114;113;113;113	C;A;C;A	96;96;98;99	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	346	porB1a	984	984	93.81	porB1a.l15.c17.ctg.1	1544	66.4	0	.	p	.	0	H40fs	FSHIFT	118	118	C	483	483	C	113	C,A	97,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2666	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5212	153.4	0	.	p	.	0	A362V	NONSYN	1084	1086	GCC	1592	1594	GTC	161;161;160	G;T;C,T	147;146;147,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2666	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5212	153.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2165	2167	CAT	162;161;161	C;A;T	144;144;143	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	372	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1337	83.4	1	SNP	p	V57M	0	.	.	169	171	GTG	699	701	GTG	139;139;140	G;T;G	121;124;125	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
